Page last updated: 2024-12-07

4-fluoroglutamic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Fluoroglutamic acid is a synthetic analog of glutamic acid, a non-proteinogenic amino acid. It is an important tool for studying the role of glutamate in biological processes. It is known to inhibit the activity of glutamate decarboxylase, an enzyme that converts glutamate to GABA. This inhibition can lead to increased glutamate levels in the brain, which can have a range of effects, including neurotoxicity. 4-fluoroglutamic acid is also a substrate for glutamine synthetase, an enzyme that converts glutamate to glutamine. This conversion is important for maintaining the balance of neurotransmitters in the brain. 4-fluoroglutamic acid has been studied as a potential therapeutic agent for various neurological disorders, such as epilepsy and Alzheimer’s disease. It has also been investigated for its potential use in cancer treatment.'

4-fluoroglutamic acid: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID102871
SCHEMBL ID502879
MeSH IDM0115777

Synonyms (36)

Synonym
91383-48-1
4-fluoroglutamic acid
4- fluoroglutamate
4-fluoro-dl-glutamic acid, >=93%
2-amino-4-fluoropentanedioic acid
A843821
AKOS007929913
A821322
A818912
2-azanyl-4-fluoranyl-pentanedioic acid
2708-77-2
dl-erythro-4-fluoroglutamic acid
einecs 220-302-8
FT-0625456
FT-0627795
FT-0625520
FT-0618534
4-fluoro-dl-glutamic acid
SCHEMBL502879
mfcd00055778
dl-4-fluoroglutamic acid
mfcd00153159
2-amino-4-fluoro-pentanedioic acid
J-016671
STL554476
5-bromo-2,2:5,2-terthiophene-5-carboxaldehyde
CS-0201732
BBL100682
MS-20060
D87862
DTXSID40949843
glutamic acid, 4-fluoro-
HY-W141942
2-amino-4-fluoropentanedioicacid
(+/-)-2-amino-4-fluoroglutaric acid
PD063210
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (28.57)18.7374
1990's2 (14.29)18.2507
2000's4 (28.57)29.6817
2010's4 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.78 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.14%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]